Your Source for Venture Capital and Private Equity Financings

Venture Capital News: Glycomine Closes $68M Series B Funding

SAN CARLOS, CA, Glycomine has closed a $68 million Series B financing led by Abingworth and Sanofi Ventures.
Glycomine, a biotechnology company focused on developing new therapies for orphan diseases, has closed a $68 million Series B financing.

The financing was led by new investors, Abingworth and Sanofi Ventures, and joined by RiverVest Venture Partners and Remiges Ventures. In addition, all previous Series B investors- Novo Holdings A/S, Asahi Kasei Pharma Ventures, Mission BioCapital, Sanderling Ventures, and Chiesi Ventures- participated.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors

Featured Reading